Home › Eli Lilly and Price Target Raised to $93.00 at Leerink Swann
 

Keywords :   


Eli Lilly and Price Target Raised to $93.00 at Leerink Swann

2015-09-08 00:18:56| Biotech - Topix.net

The brokerage currently has an "outperform" rating on the stock. Leerink Swann's price objective points to a potential upside of 15.79% from the company's previous close.

Tags: price target raised eli

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Hurricane Leslie Graphics
06.10Hurricane Kirk Graphics
06.10Hurricane Leslie Forecast Discussion Number 15
06.10Hurricane Leslie Wind Speed Probabilities Number 15
06.10Hurricane Leslie Public Advisory Number 15
06.10Summary for Hurricane Leslie (AT3/AL132024)
06.10Hurricane Leslie Forecast Advisory Number 15
06.10Hurricane Kirk Forecast Discussion Number 27
More »